Thu, October 4, 2012
Wed, October 3, 2012
Tue, October 2, 2012
Mon, October 1, 2012
Sun, September 30, 2012
Sat, September 29, 2012
Fri, September 28, 2012
[ Fri, Sep 28th 2012 ] - Market Wire
call for signatures
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ] - Market Wire
30 a.m. Eastern
Wed, September 26, 2012
Tue, September 25, 2012
Mon, September 24, 2012
Sun, September 23, 2012
Fri, September 21, 2012

Federman &;; Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Questcor Pharmaceutical


//health-fitness.news-articles.net/content/2012/ .. -been-filed-against-questcor-pharmaceutical.html
Published in Health and Fitness on Friday, September 28th 2012 at 13:00 GMT by Market Wire   Print publication without navigation


September 28, 2012 15:42 ET

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)

OKLAHOMA CITY, OK--(Marketwire - Sep 28, 2012) - On September 26, 2012, a class action lawsuit was filed in the United States District Court for the Central District of California against Questcor Pharmaceuticals, Inc. (NASDAQ: [ QCOR ]). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is April 26, 2011 through September 21, 2012.

Plaintiff seeks to recover damages on behalf of all Questcor Pharmaceuticals, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, November 26, 2012 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:



Publication Contributing Sources